Masami Haba

Statistics

Publications

Citations

222

H-Index

Active since

2015

Affiliations

Chiba Institute of Science(Current)

Aichi Medical University

National Hospital Organization

Ehime University

The University of Osaka

Masami Haba is an author at Chiba Institute of Science specializing in carboxylesterase-activated prodrugs, carboxylesterase-mediated activation, and carboxylesterase activation.

Publications per year

2015–2021

Publications

A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial

Daisuke Tomizawa, Takako Miyamura, Toshihiko Imamura et al. · Blood · 2020 · 101 citations · Full text

Medicine, Hematology, Pediatrics +12

Hematopoietic stem cell transplantation for infants with high-risk <i>KMT2A</i> gene–rearranged acute lymphoblastic leukemia

Takayuki Takachi, Tomoyuki Watanabe, Takako Miyamura et al. · Blood Advances · 2021 · 24 citations · Full text

Medicine, Hematology, Pediatrics +16

Chemical synthesis of an indomethacin ester prodrug and its metabolic activation by human carboxylesterase 1

Masato Takahashi, Tomohiro Ogawa, Hiroshi Kashiwagi et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 22 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Effects of steric hindrance and electron density of ester prodrugs on controlling the metabolic activation by human carboxylesterase

Masato Takahashi, Ibuki Hirota, Tomoyuki Nakano et al. · Drug Metabolism and Pharmacokinetics · 2021 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis and evaluation of atorvastatin esters as prodrugs metabolically activated by human carboxylesterases

Kenta Mizoi, Masato Takahashi, Masami Haba et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 17 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

1–5 of 8